
The mRNA-based therapy, used with Keytruda, is designed specifically for each patient

The combination treatment showed a 35% reduction in the risk of disease progression

Bladder cancer affects more than 614,000 people globally each year

Weinreich will be based in Billerica, Massachusetts at the company’s Research and Development site

More than 9,700 new cases of endometrial cancer are diagnosed every year in the UK

An estimated 84,870 people will be diagnosed with bladder cancer in the US this year

More than 35,000 people in five major European countries were treated for the disease last year

More than 72,680 new cases of the disease are expected to be diagnosed in the US this year

More than 614,000 cases of bladder cancer are diagnosed globally every year

Approximately 20,890 cases of the disease are expected to be diagnosed in the US this year

Almost 1,700 people are diagnosed with bladder cancer in Scotland annually

Around half of NMIBC patients are classed as being high-risk for disease progression or recurrence